Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Change in Intangibles (2016 - 2025)

Historic Change in Intangibles for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Q3 2025 value amounting to $8449.0.

  • Cumberland Pharmaceuticals' Change in Intangibles fell 7403.18% to $8449.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $65086.0, marking a year-over-year decrease of 4865.86%. This contributed to the annual value of $113253.0 for FY2024, which is 3407.21% down from last year.
  • Per Cumberland Pharmaceuticals' latest filing, its Change in Intangibles stood at $8449.0 for Q3 2025, which was down 7403.18% from $13912.0 recorded in Q2 2025.
  • In the past 5 years, Cumberland Pharmaceuticals' Change in Intangibles ranged from a high of $1.8 million in Q4 2022 and a low of $8449.0 during Q3 2025
  • Moreover, its 5-year median value for Change in Intangibles was $35336.0 (2022), whereas its average is $134115.2.
  • As far as peak fluctuations go, Cumberland Pharmaceuticals' Change in Intangibles soared by 245173.0% in 2022, and later tumbled by 9787.97% in 2023.
  • Cumberland Pharmaceuticals' Change in Intangibles (Quarter) stood at $70317.0 in 2021, then skyrocketed by 2451.73% to $1.8 million in 2022, then crashed by 97.88% to $38044.0 in 2023, then plummeted by 35.53% to $24526.0 in 2024, then tumbled by 65.55% to $8449.0 in 2025.
  • Its Change in Intangibles was $8449.0 in Q3 2025, compared to $13912.0 in Q2 2025 and $18199.0 in Q1 2025.